Xinglai Feng

441 total citations
12 papers, 102 citations indexed

About

Xinglai Feng is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinglai Feng has authored 12 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Otorhinolaryngology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinglai Feng's work include Head and Neck Cancer Studies (9 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xinglai Feng is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xinglai Feng collaborates with scholars based in China. Xinglai Feng's co-authors include Qifeng Jin, Ting Jin, Feng Jiang, Yongfeng Piao, Xiaozhong Chen, Yuanyuan Chen, Changjuan Tao, Liming Sheng, Qiaoying Hu and Shuang Huang and has published in prestigious journals such as Oncotarget, Cancer Science and Neoplasia.

In The Last Decade

Xinglai Feng

9 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinglai Feng China 7 59 54 35 21 20 12 102
Olivier Mauvais France 6 33 0.6× 24 0.4× 36 1.0× 23 1.1× 23 1.1× 15 87
Jin Lin China 4 43 0.7× 39 0.7× 14 0.4× 11 0.5× 15 0.8× 10 90
Rex H. Lee United States 6 55 0.9× 26 0.5× 39 1.1× 8 0.4× 24 1.2× 10 108
C. Lafond France 4 45 0.8× 36 0.7× 23 0.7× 12 0.6× 21 1.1× 6 63
Behzad Bidadi United States 5 62 1.1× 50 0.9× 22 0.6× 7 0.3× 42 2.1× 23 96
Michaela K. Keck United States 6 54 0.9× 59 1.1× 18 0.5× 8 0.4× 43 2.1× 13 106
Wei-Han Hu China 4 53 0.9× 85 1.6× 49 1.4× 5 0.2× 46 2.3× 6 118
S. Marimuthu United States 4 35 0.6× 32 0.6× 25 0.7× 7 0.3× 30 1.5× 5 69
Sophie Wildsmith United Kingdom 7 86 1.5× 32 0.6× 33 0.9× 8 0.4× 36 1.8× 13 101
Gustavo Dix Junqueira Pinto Brazil 4 50 0.8× 19 0.4× 12 0.3× 8 0.4× 45 2.3× 5 84

Countries citing papers authored by Xinglai Feng

Since Specialization
Citations

This map shows the geographic impact of Xinglai Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinglai Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinglai Feng more than expected).

Fields of papers citing papers by Xinglai Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinglai Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinglai Feng. The network helps show where Xinglai Feng may publish in the future.

Co-authorship network of co-authors of Xinglai Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinglai Feng. A scholar is included among the top collaborators of Xinglai Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinglai Feng. Xinglai Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Le, Feng Jiang, Qifeng Jin, et al.. (2025). Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma. Neoplasia. 63. 101156–101156.
2.
Fang, Yuting, Feng Jiang, Qifeng Jin, et al.. (2025). Concurrent chemotherapy for older patients with locoregionally advanced nasopharyngeal carcinoma: A randomized clinical trial. Journal of Geriatric Oncology. 16(5). 102246–102246.
3.
Fang, Yuting, Feng Jiang, Qifeng Jin, et al.. (2025). Effects of Antibiotics on First-line Immunotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma. Journal of Immunotherapy. 48(6). 231–236.
4.
Fang, Yuting, Feng Jiang, Qifeng Jin, et al.. (2024). Concurrent nimotuzumab and intensity‐modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma. Cancer Science. 115(8). 2729–2737. 1 indexed citations
5.
Cao, Caineng, Feng Jiang, Qifeng Jin, et al.. (2018). Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension. Oral Oncology. 79. 27–32. 20 indexed citations
6.
Cao, Caineng, Feng Jiang, Qifeng Jin, et al.. (2018). Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy. Cancer Research and Treatment. 51(1). 73–79. 8 indexed citations
8.
Tao, Changjuan, Yuanyuan Chen, Feng Jiang, et al.. (2016). The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy. Journal of Cancer. 7(14). 2005–2011. 21 indexed citations
11.
Feng, Xinglai & Liming Sheng. (2013). Gastric adenocarcinoma with thyroid metastasis: A case study and literature review. Oncology Letters. 5(5). 1653–1655. 7 indexed citations
12.
Lü, Ke, Xinglai Feng, Qinghua Deng, et al.. (2012). Prognostic Role of Serum Cytokines in Patients with Nasopharyngeal Carcinoma. Onkologie. 35(9). 7–7. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026